NISA INVESTMENT ADVISORS, LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 247 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,936
-78.2%
1,964
-66.3%
0.00%
Q2 2023$41,085
+171087.5%
5,836
+50.8%
0.00%
Q1 2023$24
+100.0%
3,871
+106.3%
0.00%
Q4 2022$12
-100.0%
1,876
-70.9%
0.00%
-100.0%
Q3 2022$60,000
-17.8%
6,438
-2.7%
0.00%0.0%
Q2 2022$73,000
+942.9%
6,614
+1459.9%
0.00%
Q1 2022$7,0000.0%4240.0%0.00%
Q4 2021$7,000
-65.0%
424
-48.3%
0.00%
Q3 2021$20,000
-88.0%
820
-87.1%
0.00%
-100.0%
Q2 2021$166,000
-17.8%
6,3690.0%0.00%0.0%
Q1 2021$202,000
-31.8%
6,3690.0%0.00%
-50.0%
Q4 2020$296,000
+55.0%
6,369
+10.0%
0.00%0.0%
Q3 2020$191,000
+11.7%
5,791
-7.3%
0.00%0.0%
Q2 2020$171,000
+557.7%
6,245
+625.3%
0.00%
Q1 2020$26,000
+36.8%
861
+22.8%
0.00%
Q4 2019$19,000
+46.2%
7010.0%0.00%
Q3 2019$13,000
-43.5%
701
-26.2%
0.00%
Q2 2019$23,000
+155.6%
9500.0%0.00%
Q1 2019$9,000
-18.2%
950
-20.8%
0.00%
Q4 2018$11,000
+83.3%
1,200
+135.3%
0.00%
Q3 2018$6,000
-33.3%
510
-27.1%
0.00%
Q2 2018$9,000
-25.0%
7000.0%0.00%
Q1 2018$12,0007000.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,222,701$25,005,0008.92%
Broadfin Capital, LLC 4,894,361$55,062,0008.10%
GREAT POINT PARTNERS LLC 3,496,340$39,334,0006.13%
FRAZIER MANAGEMENT LLC 2,188,331$24,619,0004.51%
Prosight Management, LP 715,317$8,047,0004.49%
Avoro Capital Advisors LLC 8,662,720$97,456,0004.48%
QVT Financial LP 821,361$8,748,0002.26%
Perceptive Advisors 7,290,199$82,014,0002.19%
Rhenman & Partners Asset Management AB 1,290,495$14,518,0001.46%
EMORY UNIVERSITY 185,915$2,092,0001.37%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders